These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 85318)

  • 21. [Mechanical jaundice in the course of schistosomiasis].
    Miklaszewska J; Orzechowska K
    Przegl Lek; 1971; 27(8):545-6. PubMed ID: 5111091
    [No Abstract]   [Full Text] [Related]  

  • 22. Endemic hepatitis delta virus infection in a Greek community.
    Hadziyannis SJ; Hatzakis A; Papaioannou C; Anastassakos C; Vassiliadis E
    Prog Clin Biol Res; 1987; 234():181-202. PubMed ID: 2442775
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hepatitis B antigens systems in schistosomiasis mansoni].
    Guimarães RX; da Silva EC; Nigro SP; Kimura RT; Takeda A; de Almeida FM
    Arq Gastroenterol; 1981; 18(4):145-51. PubMed ID: 7347595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liverbiopsy because of Hbs Ag positive hepatitis revealing a non-suspected hepatic schistosomiasis. Implication for future therapy with recombinant alpha interferon?
    Loffeld RJ; Blaauboer J; Blak AG
    Acta Gastroenterol Latinoam; 1996; 26(1):35-7. PubMed ID: 9137655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hepatitis B viral markers in the liver tissue of HBs-antigen carriers].
    Mansurov KhKh; Mirodzhov GK; Tkalicheva LI
    Arkh Patol; 1984; 46(4):46-51. PubMed ID: 6375639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Management of the chronic carrier of hepatitis B surface antigen (HBsAg)].
    Ramalho F
    Acta Med Port; 1983; 4(11-12):501-8. PubMed ID: 6198872
    [No Abstract]   [Full Text] [Related]  

  • 27. Hepatitis B surface antigen carrier state in hepatosplenic schistosomiasis.
    Lyra LG; Rebouças G; Andrade ZA
    Gastroenterology; 1976 Oct; 71(4):641-5. PubMed ID: 955351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The hepatitis B problem in the Philippines.
    Basaca-Sevilla V; Cross JH; Pastrana E
    Southeast Asian J Trop Med Public Health; 1986 Mar; 17(1):75-81. PubMed ID: 3016911
    [No Abstract]   [Full Text] [Related]  

  • 29. Reversibility of hepatitis B virus-induced glomerulonephritis and chronic active hepatitis after spontaneous clearance of serum hepatitis B surface antigen.
    Knecht GL; Chisari FV
    Gastroenterology; 1978 Dec; 75(6):1152-6. PubMed ID: 710868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic Japanese schistosomiasis and hepatocellular carcinoma: ten years of follow-up in Yamanashi Prefecture, Japan.
    Iida F; Iida R; Kamijo H; Takaso K; Miyazaki Y; Funabashi W; Tsuchiya K; Matsumoto Y
    Bull World Health Organ; 1999; 77(7):573-81. PubMed ID: 10444881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship of hepatitis B e antigen, DNA polymerase activity, and titer of hepatitis B surface antigen with ongoing liver injury in chronic hepatitis B virus infection.
    Perrillo R; Campbell C; Wellinghoff W; Gelb L
    Am J Gastroenterol; 1982 Jul; 77(7):445-9. PubMed ID: 7091131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results of sclerotherapy in 100 patients comparison of the outcome between schistosomiasis and hepatitis B.
    Mohamed AE; al Karawi MA; al Otaibi R; Hanid MA
    Hepatogastroenterology; 1989 Oct; 36(5):333-6. PubMed ID: 2620900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Development of acute hepatitis due to virus B. Study of 92 cases].
    Vetencourt RJ; de Silva M; de Armas J; Betty G; Oropeza F
    G E N; 1988; 42(1):13-7. PubMed ID: 3152427
    [No Abstract]   [Full Text] [Related]  

  • 34. [Matched prospective study on chronic HBsAg carriers and primary hepatocellular cancer].
    Lu JH
    Zhonghua Zhong Liu Za Zhi; 1983 Nov; 5(6):406-8. PubMed ID: 6327215
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy of adenine arabinoside 5'-monophosphate in kidney recipients with chronic active hepatitis B: a pilot study.
    Pol S; Saltiel C; Legendre C; Carnot F; Driss F; Berthelot P; Bréchot C; Ruet C; Kreis H
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1446-9. PubMed ID: 7680158
    [No Abstract]   [Full Text] [Related]  

  • 36. Risk of hepatitis B infection among Egyptians infected with Schistosoma mansoni.
    Hyams KC; el Alamy MA; Pazzaglia G; el Ghorab NM; Sidhom O; Habib M; Dunn MA
    Am J Trop Med Hyg; 1986 Sep; 35(5):1035-9. PubMed ID: 3094391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Histopathological and immunological aspects of chronic active hepatitis].
    Budriesi N; Pigozzi S; Zamboni A; Todarello A; Rizzo S; Campanelli AR
    G Clin Med; 1982 Jan; 63(1):9-16. PubMed ID: 7106460
    [No Abstract]   [Full Text] [Related]  

  • 38. The hepatitis B carrier state--a follow-up study of 100 consecutive cases.
    Kim YI; Heathcote J; Wanless IR
    Clin Invest Med; 1987 Sep; 10(5):383-7. PubMed ID: 3677506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Active chronic hepatitis caused by the B virus (ACH-B). Analysis of a series of cases].
    Romeo F; Russo A; Liuzzo P
    Recenti Prog Med; 1980 Dec; 69(6):644-69. PubMed ID: 6166033
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hepatitis B virus-related nephropathy in adults].
    Katagiri M
    Nihon Jinzo Gakkai Shi; 1986 Nov; 28(11):1437-47. PubMed ID: 3820821
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.